» Articles » PMID: 9771714

Tumour Amplified Kinase STK15/BTAK Induces Centrosome Amplification, Aneuploidy and Transformation

Overview
Journal Nat Genet
Specialty Genetics
Date 1998 Oct 15
PMID 9771714
Citations 446
Authors
Affiliations
Soon will be listed here.
Abstract

The centrosomes are thought to maintain genomic stability through the establishment of bipolar spindles during cell division, ensuring equal segregation of replicated chromosomes to two daughter cells. Deregulated duplication and distribution of centrosomes have been implicated in chromosome segregation abnormalities, leading to aneuploidy seen in many cancer cell types. Here, we report that STK15 (also known as BTAK and aurora2), encoding a centrosome-associated kinase, is amplified and overexpressed in multiple human tumour cell types, and is involved in the induction of centrosome duplication-distribution abnormalities and aneuploidy in mammalian cells. STK15 amplification has been previously detected in breast tumour cell lines and in colon tumours; here, we report its amplification in approximately 12% of primary breast tumours, as well as in breast, ovarian, colon, prostate, neuroblastoma and cervical cancer cell lines. Additionally, high expression of STK15 mRNA was detected in tumour cell lines without evidence of gene amplification. Ectopic expression of STK15 in mouse NIH 3T3 cells led to the appearance of abnormal centrosome number (amplification) and transformation in vitro. Finally, overexpression of STK15 in near diploid human breast epithelial cells revealed similar centrosome abnormality, as well as induction of aneuploidy. These findings suggest that STK15 is a critical kinase-encoding gene, whose overexpression leads to centrosome amplification, chromosomal instability and transformation in mammalian cells.

Citing Articles

Aurora kinase A expression in pleomorphic adenoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma of salivary glands: an immunohistochemical study.

Zare R, Izadi L, Alarcon-Sanchez M, Taghva M, Ranjbar M BMC Oral Health. 2025; 25(1):89.

PMID: 39825351 PMC: 11740330. DOI: 10.1186/s12903-024-05276-5.


Post-transcriptional control drives Aurora kinase A expression in human cancers.

Cacioppo R, Rad D, Pagani G, Gandellini P, Lindon C PLoS One. 2024; 19(11):e0310625.

PMID: 39527514 PMC: 11554201. DOI: 10.1371/journal.pone.0310625.


Unraveling molecular characteristics and tumor microenvironment dynamics of neuroendocrine prostate cancer.

Heimdorfer D, Artamonova N, Culig Z, Heidegger I J Cancer Res Clin Oncol. 2024; 150(10):462.

PMID: 39412660 PMC: 11485041. DOI: 10.1007/s00432-024-05983-0.


Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints.

Liu H, Cali Daylan A, Yang J, Tanwar A, Borczuk A, Zhang D Cancers (Basel). 2024; 16(16).

PMID: 39199578 PMC: 11352996. DOI: 10.3390/cancers16162805.


Contribution of AurkA/TPX2 Overexpression to Chromosomal Imbalances and Cancer.

Polverino F, Mastrangelo A, Guarguaglini G Cells. 2024; 13(16).

PMID: 39195284 PMC: 11353082. DOI: 10.3390/cells13161397.